Lv12
36 积分 2023-10-24 加入
In vivo human T cell engineering with enveloped delivery vehicles
13分钟前
待确认
A New Approach to In Vivo Transformation of Killer T cells
1小时前
已完结
Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease
22小时前
已完结
Transplantation of ovarian granulosa-like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure
23小时前
已完结
Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering
1天前
已完结
Sequential factor delivery enables efficient workflow for universal gene editing in clinical grade iPS cells
1天前
已完结
Engineered retroviruses map ligand–receptor interactions
4天前
已完结
Antigen identification and high-throughput interaction mapping by reprogramming viral entry
4天前
已完结
ThePmed1Gene Promoter of Human FcγRIIIA Can Function as a NK/T Cell-Specific Restriction Element, Which Involves Binding of Sp1 Transcription Factor
4天前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
5天前
已完结
皖公网安备34019202002308
